Among the various glucose-lowering agents used to treat T2D, 2 classes of incretin-based therapies, glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1RA) and dipeptidyl peptidase-4 (DPP-4) inhibitors (DPP4i), lower postprandial TGs (5, 6)
If a Clinical Difference Statement is not provided, the prescription will be cancelled and the patient will be referred to the commercially available product, if available
per month with GLP Elite
Will I see other clinicians in the practice when Im pregnant
This compound, with its role in energy production and potential antioxidant properties, is gaining popularity among athletes and fitness enthusiasts
Research suggests that whilst GLP-1 medications effectively promote weight loss, they may also contribute to loss of lean muscle mass alongside fat mass if nutritional intake is inadequate